JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Ultrasound measurements of the bile ducts and gallbladder: normal ranges and effects of age, sex, cholecystectomy, and pathologic states.

OBJECTIVE: The objectives of this study were to determine the normal values and ranges for bile duct and gallbladder measurements, adjusted for demographic data, and to assess the effects of a variety of pathologic states on these values.

METHODS: Four thousand one hundred nineteen abdominal ultrasounds were retrospectively analyzed. The values for the extrahepatic bile duct (EHD), left (LIHD) and right (RIHD) intrahepatic ducts, gallbladder wall thickness, and gallbladder volume in "normal" patients were evaluated with respect to age, sex, ethnicity, and cholecystectomy status. These values were compared using multivariate analysis to those in a variety of diseased states, including cirrhosis, fatty liver, gallstones, sludge, cholecystitis, and biliary obstruction.

RESULTS: One thousand four hundred eighty-four of the 4119 examinations were classified as normal. The mean EHD, RIHD, LIHD, and gallbladder wall thickness and volume measurements in normal patients were 3.8 ± 1.6 mm, 1.9 ± 1.9 mm, 1.9 ± 1.1 mm, 2.6 ± 1.6 mm, and 242 ± 234 mL, respectively.There were small increases in EHD diameter with age (+0.02 ± 0.11 mm/y, P < 0.001), female sex (+0.3 ± 1.6 mm, P < 0.0001), and cholecystectomy (+1.0 ± 1.6 mm, P < 0.0001) and a small decrease with fatty liver (-0.4 ± 1.6 mm, P = 0.0003). The gallbladder wall was thicker in patients with gallstones (+0.4 ± 1.4 mm, P = 0.0049), sludge (+0.5 ± 1.4 mm, P = 0.0019), and acute cholecystitis (+3.1 ± 1.6 mm, P < 0.0001). With biliary obstruction, the mean EHD, RIHD, LIHD, and gallbladder volume measurements were 6.0 ± 2.1 mm, 4.2 ± 1.4 mm, 4.1 ± 1.4 mm, and 171 ± 207 mL, respectively (P < 0.0001 for all values).

CONCLUSIONS: This study clarifies normal values and ranges for bile duct and gallbladder measurements, adjusted for demographic data, and evaluates these measurements in a variety of common pathologic states.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app